BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 14740424)

  • 1. Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis.
    Salvarani C; Cantini F; Boiardi L; Hunder GG
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S23-8. PubMed ID: 14740424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical differentiation between giant cell (temporal) arteritis and Takayasu's arteritis.
    Michel BA; Arend WP; Hunder GG
    J Rheumatol; 1996 Jan; 23(1):106-11. PubMed ID: 8838517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
    Parikh M; Miller NR; Lee AG; Savino PJ; Vacarezza MN; Cornblath W; Eggenberger E; Antonio-Santos A; Golnik K; Kardon R; Wall M
    Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Takayasu's arteritis and giant cell arteritis].
    Saito T; Hasegawa S
    Ryoikibetsu Shokogun Shirizu; 1994; (4):590-3. PubMed ID: 7911849
    [No Abstract]   [Full Text] [Related]  

  • 6. [Large-vessel vasculitides].
    Eklund KK; Pettersson T
    Duodecim; 2011; 127(15):1539-47. PubMed ID: 21995124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant cell arteritis with an erythrocyte sedimentation rate lower than 50.
    Martínez-Taboada VM; Blanco R; Armona J; Uriarte E; Figueroa M; Gonzalez-Gay MA; Rodriguez-Valverde V
    Clin Rheumatol; 2000; 19(1):73-5. PubMed ID: 10752506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control study.
    Liozon E; Parreau S; Dumonteil S; Gondran G; Bezanahary H; Ly KH; Fauchais AL
    Rheumatol Int; 2023 Jul; 43(7):1323-1331. PubMed ID: 37024620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term complications, monitoring and interventional treatment of large vessel vasculitis].
    Wipfler-Freißmuth E; Dejaco C; Both M
    Z Rheumatol; 2020 Aug; 79(6):523-531. PubMed ID: 32430565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein.
    Laria A; Zoli A; Bocci M; Castri F; Federico F; Ferraccioli GF
    Clin Rheumatol; 2012 Sep; 31(9):1389-93. PubMed ID: 22820967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?
    Furuta S; Cousins C; Chaudhry A; Jayne D
    J Rheumatol; 2015 Feb; 42(2):300-8. PubMed ID: 25399386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides.
    Tombetti E; Hysa E; Mason JC; Cimmino MA; Camellino D
    Curr Rheumatol Rep; 2021 Feb; 23(3):17. PubMed ID: 33569633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Large vessel vasculitis: giant cell arteritis and Takayasu arteritis].
    Petitpierre S; Bart PA; Leimgruber A; Spertini F; Prior J; Spertini F
    Rev Med Suisse; 2007 Apr; 3(108):1056-60, 1062-3. PubMed ID: 17552258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal or Takayasu's arteritis?
    Kulshrestha M; Etti R
    Neth J Med; 1996 Jan; 48(1):45-6. PubMed ID: 8775752
    [No Abstract]   [Full Text] [Related]  

  • 16. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study.
    Salvarani C; Hunder GG
    Arthritis Rheum; 2001 Apr; 45(2):140-5. PubMed ID: 11324777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-vessel GCA or a late presentation of Takayasu's arteritis?
    Akter F; Ward K
    BMJ Case Rep; 2012 May; 2012():. PubMed ID: 22669872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What to do when the Diagnosis of Giant Cell Arteritis and Takayasu's Arteritis Overlap.
    Katz-Agranov N; Tanay A; Bachar DJ; Zandman-Goddard G
    Isr Med Assoc J; 2015 Feb; 17(2):123-5. PubMed ID: 26223093
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors of left ventricular dysfunction in patients with Takayasu's or giant cell aortitis.
    Pfizenmaier DH; Al Atawi FO; Castillo Y; Chandrasekaran K; Cooper LT
    Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S41-5. PubMed ID: 15675134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Takayasu's arteritis and giant cell (temporal or cranial) arteritis.
    Hashimoto H
    Intern Med; 2000 Jan; 39(1):4-5. PubMed ID: 10674838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.